Leaman John Harold 4
4 · Traws Pharma, Inc. · Filed Nov 25, 2025
Insider Transaction Report
Form 4
Leaman John Harold
Director
Transactions
- Award
Stock Option (right to purchase)
2025-11-21+12,770→ 12,770 totalExercise: $2.31Exp: 2035-11-21→ Common Stock (12,770 underlying)
Footnotes (1)
- [F1]These options vest over three years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary.